Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

@article{Tefferi2013SurvivalAP,
  title={Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study},
  author={A. Tefferi and E. Rumi and G. Finazzi and H. Gisslinger and A. Vannucchi and F. Rodeghiero and M. Randi and R. Vaidya and M. Cazzola and A. Rambaldi and B. Gisslinger and L. Pieri and M. Ruggeri and I. Bertozzi and N. Sulai and I. Casetti and A. Carobbio and G. Jeryczynski and D. Larson and L. M{\"u}llauer and A. Pardanani and J. Thiele and F. Passamonti and T. Barbui},
  journal={Leukemia},
  year={2013},
  volume={27},
  pages={1874 - 1881}
}
  • A. Tefferi, E. Rumi, +21 authors T. Barbui
  • Published 2013
  • Medicine
  • Leukemia
  • Under the auspices of an International Working Group, seven centers submitted diagnostic and follow-up information on 1545 patients with World Health Organization-defined polycythemia vera (PV). At diagnosis, median age was 61 years (51% females); thrombocytosis and venous thrombosis were more frequent in women and arterial thrombosis and abnormal karyotype in men. Considering patients from the center with the most mature follow-up information (n=337 with 44% of patients followed to death… CONTINUE READING
    Erdheim – Chester Disease With Multiorgan Involvement , Following Polycythemia
    Approach to MPN Symptom Assessment
    Polycythaemia Vera Optimising the Use of Ruxolitinib in Inadequately Controlled Polycythaemia
    Highly Influenced
    Open Access
    Immunotherapy and polycythemia vera
    Open Access

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 53 REFERENCES